Form 10-KT/A - Transition reports [Rule 13a-10 or 15d-10]: [Amend]
SEC Accession No. 0001520138-24-000290
Filing Date
2024-08-22
Accepted
2024-08-22 14:00:56
Documents
78
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-KT/A esgh-20240813_10ka.htm   iXBRL 10-KT/A 802657
2 EX-31.1 esgh-20240813_ex31z1.htm EX-31.1 10761
3 EX-32.1 esgh-20240813_ex31z2.htm EX-32.1 4663
9 GRAPHIC image_001.jpg GRAPHIC 39526
10 GRAPHIC image_002.jpg GRAPHIC 103201
  Complete submission text file 0001520138-24-000290.txt   4841686

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE esgh-20231231.xsd EX-101.SCH 40209
5 XBRL CALCULATION FILE esgh-20231231_cal.xml EX-101.CAL 62860
6 XBRL DEFINITION FILE esgh-20231231_def.xml EX-101.DEF 118993
7 XBRL LABEL FILE esgh-20231231_lab.xml EX-101.LAB 319028
8 XBRL PRESENTATION FILE esgh-20231231_pre.xml EX-101.PRE 265586
80 EXTRACTED XBRL INSTANCE DOCUMENT esgh-20240813_10ka_htm.xml XML 454529
Mailing Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348
Business Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348 267-467-5871
ESG Inc. (Filer) CIK: 0001883835 (see all company filings)

EIN.: 871918342 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-KT/A | Act: 34 | File No.: 000-56532 | Film No.: 241231434
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)